This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a ... Empagliflozin (Jardiance) to treat type 2
QD: News Every Day--Teens with type 2 diabetes likely to need combination therapy sooner. ... A majority of teenagers with type 2 diabetes may require combination treatment or insulin therapy within a few years of diagnosis, researchers concluded.
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
QD: News Every Day--'Made in America' fast food associated with heart disease, diabetes. ... The export of American fast food restaurants to Singapore was associated with a spike in diabetes and cardiovascular diseases there, a study found.
In a safety review, the FDA identified 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes treated with SGLT2 inhibitors and 19 cases of life-threatening urosepsis ... The most common adverse reaction was generalized pruritus. A notice
The guidance statement shouldn't be taken to think ACP is relaxing on diabetes,” he said. ... Kirkman, medical director of the University of North Carolina Diabetes Care Center clinical trials unit in Chapel Hill.
Dads, dudes, diabetes and duty. I am, and have long been, on the masthead at Men's Health magazine as an editorial advisor, with contributions focused principally on weight control. ... The spread of Type 2 diabetes among children is already yesterday's
Albiglutide (Tanzeum) to treat type 2 diabetes in adults, along with diet and exercise. ... treat type 1 diabetes or diabetic ketoacidosis, or as a first-line therapy.
We know that children now get Type 2 diabetes, while a generation ago it was called "adult onset" diabetes, because the condition in children was essentially unheard of. ... In an age of epidemic obesity and diabetes, chefs can shoulder the
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.